Status:
UNKNOWN
Pathology of Hepatitis c Nephropathy
Lead Sponsor:
Assiut University
Conditions:
Cryoglobulinaemia Due to Chronic Hepatitis C
Eligibility:
All Genders
20-60 years
Brief Summary
Hepatitis c associated glomerulonephritis is an immune complex disease that occurs in 21% of patients who have HCV infection.
Detailed Description
Hepatitis C virus infection is a major public health problem with an estimated global prevalence of 3% and an estimated 5-20% of infected patients will develop liver cirrhosis .The Prevalence of Hepat...
Eligibility Criteria
Inclusion
- it will be conducted on chronic hepatitis C patients with chronic kidney disease .
- The participants will be classified according to their estimated GFR by modified MDRD equation and
- they will be recruited from the renal unit of internal medicine, Assiut University Hospitals and assiut hepatitis viruses unit-ministry of health, Egypt.
Exclusion
- Patients will be excluded if the underlying causes of CRF are as follows:
- chronic pyelonephritis,obstructive uropathy,Polycystic kidney disease,Patients with ESRD on regular hemodialysis,patients with advanced liver cirrhosis,hepatocellular carcinoma,Patients on steroids or immunosuppressive drugs and Solitary kidney.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03476031
Start Date
November 1 2018
End Date
December 1 2019
Last Update
March 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University
Asyut, Egypt, 7115115